rEVO Biologics Employee Directory
PharmaceuticalsMassachusetts, United States11-50 Employees
rEVO Biologics, Inc. is a privately held biopharmaceutical company based in the Boston area, Framingham, Massachusetts. It operates as a subsidiary of LFB Biotechnologies S.A. and has its origins dating back to its incorporation in 1993, undergoing name changes before adopting its current designation in 2013. The company focuses on developing therapies for rare diseases, with its lead product being ATryn, an antithrombin produced recombinantly for patients with hereditary antithrombin deficiency. Beyond this indication, rEVO is pursuing additional applications for ATryn, including an ongoing Phase 3 trial in pregnant women for early onset preeclampsia. The organization seeks to address specialized medical markets by advancing therapies that improve accessibility for these conditions, while engaging scientists, business professionals, and healthcare experts who share an entrepreneurial approach.